Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Relypsa Inc (NASDAQ:RLYP)

18.49
Delayed Data
As of 4:00pm ET
 -0.01 / -0.05%
Today’s Change
10.26
Today|||52-Week Range
35.97
-34.76%
Year-to-Date
5 Best-Positioned Biotech Stocks on Brexit Volatility
Jun 28 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close18.50
Today’s open18.55
Day’s range18.29 - 19.29
Volume2,936,125
Average volume (3 months)2,904,777
Market cap$827.8M
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-80.66%
Earnings growth (this year)-34.86%
Earnings growth (next 5 years)+21.09%
Revenue growth (last year)--
P/E ratioNM
Price/Sales62.18
Price/Book4.20

Competitors

 Today’s
change
Today’s
% change
AVXSAveXis Inc+1.13+2.97%
NTLAIntellia Therapeutic...-0.33-1.55%
MNTAMomenta Pharmaceutic...+0.25+2.31%
CHRSCoherus BioSciences ...-0.05-0.30%
Data as of 4:00pm ET, 07/01/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$1.52
Annual revenue (last year)$18.6M
Annual profit (last year)-$178.7M
Net profit margin-963.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John A. Orwin
Chief Financial Officer &
Senior Vice President
Kristine McClintock Ball
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers

Search for Jobs